cycloheximide has been researched along with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bancalari, E; Duncan, MR; Grotendorst, G; Kasisomayajula, K; Peng, J; Wu, S | 1 |
| Babaahmadi-Rezaei, H; Dayati, P; Ghaffari, MA; Kamato, D; Little, PJ; Mohammad Zadeh, G; Sharifat, N | 1 |
2 other study(ies) available for cycloheximide and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide
| Article | Year |
|---|---|
ALK-5 mediates endogenous and TGF-beta1-induced expression of connective tissue growth factor in embryonic lung.
Topics: Activin Receptors, Type I; Animals; Benzamides; Connective Tissue Growth Factor; Cycloheximide; Dioxoles; Female; Gene Expression Regulation; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung; Male; Mice; Morphogenesis; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; RNA, Messenger; Smad2 Protein; Transforming Growth Factor beta1 | 2007 |
Endothelin-1 (ET-1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors and de novo protein synthesis.
Topics: Animals; Benzamides; Bosentan; Cattle; Cycloheximide; Dioxoles; Endothelial Cells; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Phosphorylation; Protein Biosynthesis; Protein Synthesis Inhibitors; Receptor, Endothelin B; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad2 Protein; Sulfonamides; Transforming Growth Factor beta | 2017 |